This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Porembka, M. R. Articles by Margenthaler, J. A. Search for Related Content PubMed Articles by Porembka, M. R. Articles by Margenthaler, J. A.

Factors Associated with Lymph Node Assessment in Ductal Carcinoma in situ: Analysis of 1988–2002 Seer Data

¹ Department of Surgery, Washington University School of Medicine, St. Louis, MO 63110, USA
² Department of Community Health, Saint Louis University School of Public Health, St. Louis, MO 63104, USA
³ Alvin J. Siteman Cancer Center, Barnes-Jewish Hospital and Washington University School of Medicine, St. Louis, MO 63110, USA
⁴ Department of Medicine, Washington University School of Medicine, St. Louis, MO 63110, USA

Correspondence: Address correspondence and reprint requests to: Julie A. Margenthaler, MD; E-mail: margenthalerj{at}wudosis.wustl.edu

Background: Ductal carcinoma in situ (DCIS) represents 20–30% of mammographically detected breast cancers, but the role of lymph node assessment (LNA) in women with DCIS remains unclear.

Methods: Using the 1988–2002 Surveillance, Epidemiology, and End Results (SEER) Program data, we conducted a case–control study to identify variables associated with (1) LNA in DCIS patients and (2) use of axillary lymph node dissection (ALND) compared with sentinel lymph node biopsy (SLNB). Using separate multivariable logistic regression models, we identified patient and tumor-related factors associated with LNA (1988–2002) and with the method used (recorded only in 1998–2002). We report adjusted odds ratios (aORs) and 95% confidence intervals (CIs).

Results: Of 23,502 women with DCIS, 37% underwent mastectomy and 63% underwent breast-conservation therapy (BCT); 6,650 cases (28%) underwent LNA. Women younger than 80 years (aOR 1.47; 95% CI 1.24–1.75) or who had mastectomy (aOR 11.06; 95% CI 10.30–11.90), tumor size greater than 9 mm (aORs ranged from 1.27–1.97 for 10-mm increments from 10 to 50 mm or more) or poorly differentiated grade (aOR 1.33; 95% CI 1.11–1.55) were more likely to have had a LNA. From 1998 to 2002, 10,637 women underwent resection for DCIS (21% mastectomy; 79% BCT); of these, 2,219 (21%) had LNA (73% mastectomy; 27% BCT). Mastectomy patients were 3.52 times more likely to receive ALND (95% CI 2.71–4.57) than SLNB, after controlling for other factors.

Conclusion: Optimal guidelines for use of LNA in DCIS have not been defined. However, there appeared to be a persistent and excessive utilization of ALND for LNA in women with DCIS (1998–2002).

Key Words: Ductal carcinoma in situ • Sentinel lymph node biopsy • Axillary lymph node dissection • Surgery